O97237 AF NFT

GRIP and coiled-coil domain-containing protein

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihirqkgqo75sx7b7smykhbl6jfgcbw7sqskfegd42mvxfzgbomitu/metadata.json
IPFS of structure file: 
bafybeiflngqswave3v5josahkfbyoyve24pxjtg67er5a5cfhyzzg62bim/AF-O97237-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x46EfCa788d03A3e879DAcDb96552AB8Bbc7e20b3
First NFT owner address (bech32): 
genesis1gmhu57ydqw37s7w6ekuk254t3w78ug9ndfc7sx
Current NFT ID #530336 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
530336
Accession (UniProt):
O97237
Name::
GRIP and coiled-coil domain-containing protein
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O97237 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O97237|YGCC1_PLAF7 GRIP and coiled-coil domain-containing protein OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PF3D7_0305200 PE=1 SV=3 MNFCDNNEMNETKNFMMSNKNDDIVVDCDEYIDGNVFEKNTNMGNIYDENYNVDMKNDNLLSKLNDNISFTYTTNGQVEKQENEIKEKQNILHYQIYIDNDEDKYKYCSNSNLHKNEEEHEKGSPNNIYEELDNNLEKKYFYYNSDSKHCIDEKNETNDLENENVVTSMDVSYENVLNDNFIKSRSTSINYTDNSFVLNKENLKSSHHINGYYINDHDNIKSDIINDHDNIKSDIINDYDNIKGDKINEYDNIKSDKINDYDNIKSDIINDYDNIKSDKINDYDNIKSDKINDYDNIKSDKINDYDNIKSDKINDYDNIKSDKINHYDNIKSDKINDYDNIKSDKINDYDNIKSDKINDYDNIKYNDDSQINNNVSNKVNSPDDDPNTYEKDKKDIINCNIYEENKNNMNNIIHNDKENIHMVDTGKNEENNNIDNKNNDDINKVNVLTRVDTENYILNEENILPLHTNDDVTKLLDEINDLKNTIENMKKEKINLLSKFKAYTLNNKKELEELKIKCKNKEEQIKMYENKLQNKEDEIMNYVNEIQNKDKKIESYHIKLHNKEEEIMNYVNEIQNKEEEIIKYVNELQNSDVQKEKKELKTINEVLKNTNEKLEKEITSLLGEMKKIEEENKVLKIFKEEKNKINNEKVTQIKGDDINDDNDMKFKQILLDNKTFNKLLVNELNIVEENILFCFSIDKDKNRLLVCIKQNDDNFFVIPNCIFDEKFPGLQKKTESMIIQDIHEKEILELKNKQMNELYILKKEKEDIYKEYEEYKKKVTSLINETNYNYKNIEEKENEIKELNNTLNKYKEEMNNYKEEIIVINEKYKLLEIELCKEKNIRDQQNVGISDLKKKMLKEKIELEKKYKEQYEKETQQKINDMKIIFDNKEKILQDQIDDLLHKIEKLTFSNDEKTKTIENLQIYMDNDDNIMNQEGIQKNEKKQIIDNPINTDEKDLLNYIPDNHINSDLNHINSNVENDYVEKRNKNNVHLSKKETNYQHNINEQENDNNNNNNNNNNNNNVEKLKSINSTNTSIPIYPYEYKKIRKKLETYEILLNEQQEGKKKMTEEINSLKNQVKNYESINGNYQHIIYQKNILSNFIAQIPSRIQVDDYVSVIFNSFNFSNQEIEAINIKRSKK